Caplacizumab
Records for this ingredient, by country (identity only).
ATC B01AX07 · 7 markets · 7 records
GB 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionCablivi 10mg powder and solvent for solution for injection vials
ES 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionCablivi
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionカブリビ注射用10mg
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionCABLIVI 10 mg, poudre et solvant pour solution injectable
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.